Assay Designs
Acquisition in 2009
Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.
BIOMOL International, LP engages in the research, development, and production of reagents for biomedical research. It offers specialty biochemicals; drug discovery kits, bulk enzymes, and substrates for inhibitor screening of therapeutic targets; and compound libraries for receptor de-orphaning, assay development, and chemical genomics. The company provides products in the areas of signal transduction, lipid signaling, post translational modifications, proteolysis, ubiquitons and zomes, and neuroscience. It also offers custom services for drug discovery programs. BIOMOL International, LP provides its products through an online catalog, as well as through distributors in Africa, Asia, Australia, Central America, Europe, the Middle East, North America, South America, and the United Kingdom. The company was founded in 1983 and is based in Plymouth Meeting, Pennsylvania. It has production facilities in the Greater Philadelphia region; and Exeter, the United Kingdom. As of May 8, 2008, BIOMOL International, LP operates as a subsidiary of Enzo Life Sciences, Inc.